We use cookies

Our website uses essential cookies and, with your consent, additional cookies to measure performance and improve our services. Cookie Policy.

You can change your choice at any time.

MMedXYNews
HomeVideos
© 2026 MedXY
Contact usAbout usPrivacy PolicyMedXY story
MedXY AI/MedXY News/Infectious Diseases

Infectious Diseases

Ask MedXY AI
What is the latest evidence?Key clinical updatesGuideline changes

Latest news

Early Shenfu Injection in Sepsis: Impact on Hemodynamics, Mortality, and Microcirculation in a Multicenter RCT
Critical Carehemodynamicsmicrocirculation

Early Shenfu Injection in Sepsis: Impact on Hemodynamics, Mortality, and Microcirculation in a Multicenter RCT

By MedXY|Jul 17, 2026

Early administration of Shenfu injection in septic ICU patients did not reduce vasopressor use but was associated with lower mortality and improved microcirculation, warranting further validation.

Hepatitis C Screening Among Persons Experiencing Homelessness in Emergency Departments: Insights from the DETECT Hep C Screening Trial and Related Evidence
Clinical Updatesemergency departmentHepatitis C

Hepatitis C Screening Among Persons Experiencing Homelessness in Emergency Departments: Insights from the DETECT Hep C Screening Trial and Related Evidence

By MedXY|Jul 17, 2026

Emergency departments serve as vital venues for hepatitis C virus screening, particularly for persons experiencing homelessness who exhibit higher HCV prevalence and face healthcare access barriers. Evidence supports nontargeted screening i

Unraveling the Diarrheal Outbreaks: Understanding Cyclospora and Cryptosporidiosis in the United States
GastroenterologyCryptosporidiosisCyclospora

Unraveling the Diarrheal Outbreaks: Understanding Cyclospora and Cryptosporidiosis in the United States

By MedXY|Jul 17, 2026

This article explores recent outbreaks of Cyclospora and Cryptosporidium infections in the U.S., their transmission, clinical features, diagnosis, treatment, and prevention, highlighting the public health impact and clinical challenges.

Decoding the Pulmonary Immune Landscape in Influenza: Insights from a Large-Scale Single-Cell Atlas
Infectious Diseasesalveolar macrophagesinfluenza

Decoding the Pulmonary Immune Landscape in Influenza: Insights from a Large-Scale Single-Cell Atlas

By MedXY|Jul 17, 2026

A comprehensive single-cell atlas of lung immune cells reveals distinct immune responses in mild versus severe influenza, highlighting neutrophil dysfunction and lymphocyte impairment as key drivers of pathology.

Harnessing Precision Medicine: The APS Consortium’s National Platform for Phenotyping ARDS, Pneumonia, and Sepsis
Critical CareARDScritical care

Harnessing Precision Medicine: The APS Consortium’s National Platform for Phenotyping ARDS, Pneumonia, and Sepsis

By MedXY|Jul 15, 2026

The APS Consortium establishes a large, prospective cohort of critically ill adults with ARDS, pneumonia, and sepsis to enable biologically based phenotyping, leveraging rich clinical data and biospecimens for improved understanding and the

Persistent Elevated Risk of Severe COVID-19 Outcomes in Pregnant and Postpartum Individuals Beyond the Pandemic Emergency
Infectious DiseasesPregnancypostpartum

Persistent Elevated Risk of Severe COVID-19 Outcomes in Pregnant and Postpartum Individuals Beyond the Pandemic Emergency

By MedXY|Aug 18, 2026

Pregnant and postpartum individuals continue to face higher risks of severe COVID-19 outcomes, including hospitalization and pneumonia, even after the pandemic emergency has ended, emphasizing the need for ongoing vigilance and tailored cli

Unraveling Hepatitis B-Induced Liver Fibrosis: The Critical Role of Pyruvate, PPARα, and Reactive Oxygen Species
GastroenterologyHBVliver fibrosis

Unraveling Hepatitis B-Induced Liver Fibrosis: The Critical Role of Pyruvate, PPARα, and Reactive Oxygen Species

By MedXY|Jul 10, 2026

This article explores the mechanism by which HBV induces liver fibrosis through pyruvate-dependent ROS production and PPARα inhibition, highlighting novel therapeutic targets for chronic hepatitis B management.

Point-of-Care Multiplex PCR Testing in Nursing Homes: Impact on Respiratory Outbreak Management and Emergency Transfers
Infectious Diseasesnursing homesoutbreak management

Point-of-Care Multiplex PCR Testing in Nursing Homes: Impact on Respiratory Outbreak Management and Emergency Transfers

By MedXY|Jul 9, 2026

A cluster randomized trial in Toronto nursing homes found that on-site multiplex PCR testing improved viral detection and reduced emergency department transfers during respiratory outbreaks, though it did not alter outbreak size or frequenc

Long-term Neurological Sequelae in Adult Survivors of Ebola Virus Disease: Insights from a 7-Year Liberian Cohort Study
Infectious DiseasesCognitive dysfunctionEbola virus disease

Long-term Neurological Sequelae in Adult Survivors of Ebola Virus Disease: Insights from a 7-Year Liberian Cohort Study

By MedXY|Jul 5, 2026

This study characterizes neurological complications in adult Ebola survivors over 7 years, demonstrating persistent cognitive and neuropsychiatric deficits despite gradual improvement, underscoring the need for ongoing neurological follow-u

Ebola Virus in Pregnancy: Current Insights and Clinical Implications During the DR Congo Outbreak
Infectious DiseasesVertical transmissionPregnancy

Ebola Virus in Pregnancy: Current Insights and Clinical Implications During the DR Congo Outbreak

By MedXY|Aug 18, 2026

This article reviews updated clinical understanding of Ebola virus disease in pregnancy amid the Democratic Republic of Congo outbreak, highlighting maternal outcomes, risks of vertical transmission, treatment challenges, and the critical n

Clinical Metagenomics in Sepsis: Insights from the DigiSep Randomized Controlled Trial
Critical Careclinical outcomeshealth-related quality of life

Clinical Metagenomics in Sepsis: Insights from the DigiSep Randomized Controlled Trial

By MedXY|Jul 2, 2026

The DigiSep trial assessed the impact of metagenomic next-generation sequencing (mNGS) on sepsis outcomes. While primary endpoint improvement was not significant, secondary analyses revealed benefits in mechanical ventilation duration, shoc

Evaluating the Safety of Same-Day COVID-19 and Influenza Vaccination: Insights from a Large Veterans Affairs Target Trial Emulation
Infectious DiseasesCOVID-19 vaccineinfluenza vaccine

Evaluating the Safety of Same-Day COVID-19 and Influenza Vaccination: Insights from a Large Veterans Affairs Target Trial Emulation

By MedXY|Jul 2, 2026

A large U.S. Veterans Affairs study found no increased 90-day risk of adverse events after same-day COVID-19 and influenza vaccination compared to influenza vaccination alone, supporting the safety of coadministration with updated COVID-19

Therapeutic Implications of MARS Therapy-Induced Piperacillin Clearance in Critical Liver Failure Patients
Critical CareAcute liver failureMARS therapy

Therapeutic Implications of MARS Therapy-Induced Piperacillin Clearance in Critical Liver Failure Patients

By MedXY|Jun 30, 2026

MARS therapy significantly reduces total plasma piperacillin levels by approximately one-third per session in critically ill liver failure patients, underscoring the need for therapeutic drug monitoring and individualized antibiotic dosing.

Long-Term Assessment of Rose Bengal Photodynamic Therapy in Infectious Keratitis: Insights from the REAGIR Randomized Trial
Infectious Diseasesclinical trialInfectious Keratitis

Long-Term Assessment of Rose Bengal Photodynamic Therapy in Infectious Keratitis: Insights from the REAGIR Randomized Trial

By MedXY|Jun 29, 2026

A 12-month follow-up of the REAGIR trial found no significant benefit of adjunctive rose bengal photodynamic therapy with green light over sham treatment in improving visual acuity, scar size, or complication rates in infectious keratitis.

Functional Anti-preS1 Antibody Responses and Their Role in Viral Control in Chronic Hepatitis B
Clinical Updateschronic hepatitis BHBV therapy

Functional Anti-preS1 Antibody Responses and Their Role in Viral Control in Chronic Hepatitis B

By MedXY|Jun 29, 2026

This review synthesizes evidence on preS1 antigen and anti-preS1 IgG dynamics in chronic hepatitis B, highlighting their correlations with viral replication, liver inflammation, and functional cure, and elucidates the neutralising potential

Evaluating the Safety of Prenatal RSVpreF Vaccination: Implications for Obstetric and Neonatal Outcomes
Infectious DiseasesRSV vaccinePregnancy

Evaluating the Safety of Prenatal RSVpreF Vaccination: Implications for Obstetric and Neonatal Outcomes

By MedXY|Aug 18, 2026

A large-scale VSD study found that prenatal vaccination with bivalent prefusion F RSV vaccine is generally safe, showing no increased risk for preterm birth, stillbirth, or small-for-gestational-age births but a slight increase in hypertens

Hantavirus in Pregnancy: Why Obstetricians Need a High Index of Suspicion
Infectious DiseasesPregnancyhantavirus

Hantavirus in Pregnancy: Why Obstetricians Need a High Index of Suspicion

By MedXY|Aug 18, 2026

Hantavirus infection in pregnancy is rare but potentially fatal. Obstetricians should suspect it after rodent or travel exposure, recognize rapid respiratory decline, and prioritize supportive critical care because no proven antiviral thera

Early, Broad Oseltamivir Prophylaxis May Cut Hospitalizations in Nursing Home Influenza Outbreaks
Infectious Diseasesinfluenzanursing homes

Early, Broad Oseltamivir Prophylaxis May Cut Hospitalizations in Nursing Home Influenza Outbreaks

By MedXY|Jun 15, 2026

Prompt oseltamivir prophylaxis covering at least 70% of eligible nursing home residents within 2 days of outbreak detection was associated with fewer hospitalizations, but not lower mortality.

Fast, Broad Oseltamivir Use in Nursing Home Flu Outbreaks May Cut Hospitalizations
Infectious Diseaseschemoprophylaxisinfluenza

Fast, Broad Oseltamivir Use in Nursing Home Flu Outbreaks May Cut Hospitalizations

By MedXY|Jun 15, 2026

In a real-world target trial emulation, starting oseltamivir prophylaxis within 2 days for at least 70% of eligible nursing home residents was linked to fewer hospitalizations, but not lower short-term mortality.

Post-infection Gut-Brain Disorders Affect About 1 in 10 People With DGBI Worldwide, With Distinct Psychological and Regional Patterns
Gastroenterologygastroenteritisglobal epidemiology

Post-infection Gut-Brain Disorders Affect About 1 in 10 People With DGBI Worldwide, With Distinct Psychological and Regional Patterns

By MedXY|Jun 10, 2026

A large 26-country survey found that post-infection disorders of gut-brain interaction account for 10.5% of DGBI cases and are linked to younger age, male sex, urban living, anxiety, and greater somatic symptom burden.

Prev
3 / 17
12345…17
Next
Ask MedXY AI

Most popular

Intimate Health
Five Benefits for Women Continuing Sexual Activity After Menopause
Intimate Health
Why Some Women Have a Strong Sex Drive—And Why Men Shouldn't Worry About It
Nursing & care
How often should a couple have sex?
General Surgery
Optimizing Postoperative Opioid Prescriptions After Intra-Abdominal Cancer Surgery: Comparing the 5x-Multiplier and 3-Tier Models
Intimate Health
Classic Intimacy Recommendations: How to Help Women Reach Orgasm and Enjoy Mutual Pleasure

Browse by specialty

Open language-specific specialty feeds and department pages.

news6829 articlesCardiology1403 articlesClinical Updates1315 articlesOncology1176 articlesDiabetes & Endocrinology868 articlesNeurology834 articlesPublic Health605 articlesGastroenterology586 articles
Hematology-Oncology
513 articles
Pediatrics493 articles
Internal Medicine464 articles